NO20051259L - Biaryl-diazabicykloalkanamider som nikotinacetylcholinagonister - Google Patents

Biaryl-diazabicykloalkanamider som nikotinacetylcholinagonister

Info

Publication number: NO20051259L
Authority: NO; Norway
Prior art keywords: diazabicycloalkanamides; biaryl; sup; nicotine acetylcholine; acetylcholine agonists
Prior art date: 2002-08-14

Application number

NO20051259A

Other languages

English (en)

Norwegian (no)

Inventor

Eifion Phillips

Richard Schmiesing

Glen Ernst

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-14

Filing date

2005-03-11

Publication date

2005-05-12

2005-03-11 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2005-05-12 Publication of NO20051259L publication Critical patent/NO20051259L/no

Links

POPPVIRYGJQIOF-UHFFFAOYSA-N 2-acetyloxyethyl(trimethyl)azanium;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound CC(=O)OCC[N+](C)(C)C.CN1CCCC1C1=CC=CN=C1 POPPVIRYGJQIOF-UHFFFAOYSA-N 0.000 title 1
239000000064 cholinergic agonist Substances 0.000 title 1
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
108010009685 Cholinergic Receptors Proteins 0.000 abstract 1
102000034337 acetylcholine receptors Human genes 0.000 abstract 1
239000003446 ligand Substances 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Psychology (AREA)
Addiction (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)
Steroid Compounds (AREA)

NO20051259A 2002-08-14 2005-03-11 Biaryl-diazabicykloalkanamider som nikotinacetylcholinagonister NO20051259L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0202430A SE0202430D0 (sv)	2002-08-14	2002-08-14	New Compounds
PCT/SE2003/001277 WO2004016617A1 (en)	2002-08-14	2003-08-13	Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists

Publications (1)

Publication Number	Publication Date
NO20051259L true NO20051259L (no)	2005-05-12

Family

ID=20288725

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20051259A NO20051259L (no)	2002-08-14	2005-03-11	Biaryl-diazabicykloalkanamider som nikotinacetylcholinagonister

Country Status (18)

Country	Link
US (1)	US20050239774A1 (2)
EP (1)	EP1539765B1 (2)
JP (1)	JP2006507241A (2)
KR (1)	KR20060002727A (2)
CN (1)	CN100343256C (2)
AT (1)	ATE417049T1 (2)
AU (1)	AU2003248592B2 (2)
BR (1)	BR0313234A (2)
CA (1)	CA2493920A1 (2)
DE (1)	DE60325234D1 (2)
ES (1)	ES2316848T3 (2)
IL (1)	IL166416A0 (2)
MX (1)	MXPA05001583A (2)
NO (1)	NO20051259L (2)
NZ (1)	NZ537882A (2)
SE (1)	SE0202430D0 (2)
WO (1)	WO2004016617A1 (2)
ZA (1)	ZA200501226B (2)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE521512C2 (sv)	2001-06-25	2003-11-11	Niconovum Ab	Anordning för administrering av en substans till främre delen av en individs munhåla
DE10164139A1 (de)	2001-12-27	2003-07-10	Bayer Ag	2-Heteroarylcarbonsäureamide
SE0202465D0 (sv) *	2002-08-14	2002-08-14	Astrazeneca Ab	New compounds
MXPA05003317A (es)	2002-09-25	2005-07-05	Memory Pharm Corp	Indazoles, benzotiazoles y benzoisotiazoles asi como preparacion y usos de los mismos.
PT1578422E (pt)	2002-12-20	2007-06-14	Niconovum Ab	Material particulado contendo nicotina fisicamente e quimicamente estável
DE602004023586D1 (de) *	2003-02-27	2009-11-26	Neurosearch As	Neue diazabicyclische arylderivate
CN100445285C (zh) *	2003-12-22	2008-12-24	阿斯利康(瑞典)有限公司	烟碱性乙酰胆碱受体配体
RU2389729C2 (ru)	2003-12-22	2010-05-20	Мемори Фармасьютиклз Корпорейшн	1н-индазолы, 1, 2-бензизоксазолы и 1, 2-бензизотиазолы, их получение и применение
TW200529860A (en) *	2003-12-22	2005-09-16	Astrazeneca Ab	Nicotinic acetylcholine receptor ligands
JP2007520527A (ja) *	2004-02-04	2007-07-26	ノイロサーチアクティーゼルスカブ	ニコチン性アセチルコリン受容体リガンドとしてのジアザ２環式アリール誘導体
EP1735306A2 (en)	2004-03-25	2006-12-27	Memory Pharmaceuticals Corporation	Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
CA2567977A1 (en)	2004-04-22	2006-01-05	Memory Pharmaceutical Corporation	Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
NZ551712A (en)	2004-05-07	2010-07-30	Memory Pharm Corp	1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparations and uses thereof
DE602005025902D1 (de)	2004-10-15	2011-02-24	Neurosearch As	Neue azabizyklische arylderivate und medizinische verwendung damit
CA2591817A1 (en)	2004-12-22	2006-06-29	Memory Pharmaceuticals Corporation	Nicotinic alpha-7 receptor ligands and preparation and uses thereof
EP1987032A1 (en)	2006-02-14	2008-11-05	NeuroSearch A/S	3, 9-diazabicyclo(3.3.1)non-3-yl-aryl methanone derivatives as nicotinic acetylcholine receptor agonists
AU2007224584A1 (en)	2006-03-16	2007-09-20	Niconovum Ab	Improved snuff composition
AU2007267177A1 (en)	2006-05-30	2007-12-06	Neurosearch A/S	Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use
TWI454262B (zh) *	2006-11-02	2014-10-01	Targacept Inc	菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺
SA08290475B1 (ar)	2007-08-02	2013-06-22	Targacept Inc	(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
AU2008316895A1 (en) *	2007-10-22	2009-04-30	Memory Pharmaceuticals Corporation	(1,4-diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone ligands for nicotinic acetylcholine receptors, useful for the treatment of disease
GB0724251D0 (en)	2007-12-12	2008-02-06	Univ Edinburgh	Therapeutic compounds and their use
GB0804685D0 (en)	2008-03-13	2008-04-16	Univ Edinburgh	Therapeutic compounds and their use
CN102131791B (zh)	2008-06-20	2014-12-24	阿斯利康(瑞典)有限公司	二苯并硫杂氮杂*衍生物及其用途
TW201031664A (en)	2009-01-26	2010-09-01	Targacept Inc	Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
WO2010146338A1 (en)	2009-06-15	2010-12-23	The University Of Edinburgh	Amido-isothiazole compounds and their use as inhibitors of 11beta-hsd1 for the treatment of metabolic syndrome and related disorders
US8642621B2 (en)	2009-09-16	2014-02-04	The University Of Edinburgh	(4-phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone compounds and their use
EP2531465A4 (en) *	2010-02-03	2015-12-30	Meh Associates Inc	MULTIPLE SUBSTITUTED FLUOROMETHANES AS SELECTIVE AND BIOACTIVE ISOSTERES
AU2011247116B2 (en)	2010-04-29	2015-12-03	The University Of Edinburgh	3, 3 -disubstituted- ( 8 - aza - bicyclo [3.2.1] oct- 8 - yl) -[5- (1H - pyrazol - 4 -yl) -thiophen-3 -yl] methanones as inhibitors of 11 (beta) -HSD1
PE20170923A1 (es)	2010-05-17	2017-07-12	Forum Pharmaceuticals Inc	Una forma cristalina de clorhidrato de (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida monohidratado
JP5996532B2 (ja) *	2010-07-15	2016-09-21	バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＧｍｂＨ	有害生物防除剤としての新規複素環式化合物
GB201111705D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Compounds and their use
GB201111704D0 (en)	2011-07-07	2011-08-24	Takeda Pharmaceutical	Novel compounds
JO3115B1 (ar)	2011-08-22	2017-09-20	Takeda Pharmaceuticals Co	مركبات بيريدازينون واستخدامها كمثبطات daao
EP3461481A1 (en)	2012-05-08	2019-04-03	Forum Pharmaceuticals Inc.	Methods of maintaining, treating or improving cognitive function
GB201209587D0 (en)	2012-05-30	2012-07-11	Takeda Pharmaceutical	Therapeutic compounds
MA37975B2 (fr)	2012-09-11	2021-03-31	Genzyme Corp	Inhibiteurs de synthase de glucosylcéramide
JP6478923B2 (ja)	2013-02-07	2019-03-06	ヘプタレスセラピューティクスリミテッドＨｅｐｔａｒｅｓＴｈｅｒａｐｅｕｔｉｃｓＬｉｍｉｔｅｄ	ムスカリンｍ４受容体アゴニストとしてのピペリジン−１−イル及びアゼピン−１−イルカルボキシレート
WO2014202999A1 (en)	2013-06-21	2014-12-24	Takeda Cambridge Limited	1-sulfonyl piperidine derivatives as modulators of prokineticin receptors
GB201314286D0 (en)	2013-08-08	2013-09-25	Takeda Pharmaceutical	Therapeutic Compounds
GB201318222D0 (en)	2013-10-15	2013-11-27	Takeda Pharmaceutical	Novel compounds
GB201320905D0 (en)	2013-11-27	2014-01-08	Takeda Pharmaceutical	Therapeutic compounds
TW201613864A (en)	2014-02-20	2016-04-16	Takeda Pharmaceutical	Novel compounds
GB201616839D0 (en)	2016-10-04	2016-11-16	Takeda Pharmaceutical Company Limited	Therapeutic compounds
GB201619514D0 (en)	2016-11-18	2017-01-04	Takeda Pharmaceuticals Co	Novel compounds
CN114040762A (zh)	2019-02-04	2022-02-11	建新公司	使用葡糖神经酰胺合酶(gcs)的抑制剂治疗纤毛疾病
JP2023512366A (ja)	2020-02-03	2023-03-27	ジェンザイム・コーポレーション	リソソーム蓄積性疾患と関連する神経学的症状を処置するための方法
JP2021138648A (ja)	2020-03-04	2021-09-16	武田薬品工業株式会社	経口固形製剤
AU2021311131B2 (en)	2020-07-24	2026-02-19	Genzyme Corporation	Pharmaceutical compositions comprising venglustat
GB202414193D0 (en)	2024-09-27	2024-11-13	Addex Pharmaceuticals Sa	Novel compounds
GB202414197D0 (en)	2024-09-27	2024-11-13	Addex Pharmaceuticals Sa	Novel compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3281423A (en) *	1964-02-03	1966-10-25	Merck & Co Inc	1, 3-ethanopiperazines and process
US4895943A (en) *	1988-10-25	1990-01-23	Pfizer Inc.	Preparation of 1,4-diazabicyclo(3.2.2)nonane
US5679673A (en) *	1992-09-24	1997-10-21	The United States Of America, Represented By The Department Of Health And Human Services	Aralkyl bridged diazabicycloalkane derivatives for CNS disorders
FR2791678B1 (fr) *	1999-03-30	2001-05-04	Synthelabo	Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique
FR2809731B1 (fr) *	2000-05-31	2002-07-19	Sanofi Synthelabo	Derives de 1,4-diazabicyclo-[3.2.2] nonane-pheylisoxazole, leur preparation et leur application en therapeutique
FR2809732B1 (fr) *	2000-05-31	2002-07-19	Sanofi Synthelabo	DERIVES DE 4(-2-PHENYLTHIAZOL-5-yl)-1,4-DIAZABICYCLO-[3.2.2] NONANE, LEUR PREPARATION ET LEUR APPLICATION ENTHERAPEUTIQUE
SE0202465D0 (sv) *	2002-08-14	2002-08-14	Astrazeneca Ab	New compounds
DE602004023586D1 (de) *	2003-02-27	2009-11-26	Neurosearch As	Neue diazabicyclische arylderivate
CN100445285C (zh) *	2003-12-22	2008-12-24	阿斯利康(瑞典)有限公司	烟碱性乙酰胆碱受体配体
TW200529860A (en) *	2003-12-22	2005-09-16	Astrazeneca Ab	Nicotinic acetylcholine receptor ligands

2002
- 2002-08-14 SE SE0202430A patent/SE0202430D0/xx unknown
2003
- 2003-08-13 CA CA002493920A patent/CA2493920A1/en not_active Abandoned
- 2003-08-13 MX MXPA05001583A patent/MXPA05001583A/es unknown
- 2003-08-13 ES ES03788214T patent/ES2316848T3/es not_active Expired - Lifetime
- 2003-08-13 NZ NZ537882A patent/NZ537882A/en unknown
- 2003-08-13 AU AU2003248592A patent/AU2003248592B2/en not_active Expired - Fee Related
- 2003-08-13 KR KR1020057002265A patent/KR20060002727A/ko not_active Ceased
- 2003-08-13 US US10/524,484 patent/US20050239774A1/en not_active Abandoned
- 2003-08-13 CN CNB038194791A patent/CN100343256C/zh not_active Expired - Fee Related
- 2003-08-13 DE DE60325234T patent/DE60325234D1/de not_active Expired - Fee Related
- 2003-08-13 BR BR0313234-0A patent/BR0313234A/pt not_active IP Right Cessation
- 2003-08-13 AT AT03788214T patent/ATE417049T1/de not_active IP Right Cessation
- 2003-08-13 JP JP2004529002A patent/JP2006507241A/ja active Pending
- 2003-08-13 WO PCT/SE2003/001277 patent/WO2004016617A1/en not_active Ceased
- 2003-08-13 EP EP03788214A patent/EP1539765B1/en not_active Expired - Lifetime
2005
- 2005-01-20 IL IL16641605A patent/IL166416A0/xx unknown
- 2005-02-10 ZA ZA200501226A patent/ZA200501226B/en unknown
- 2005-03-11 NO NO20051259A patent/NO20051259L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
CN100343256C (zh)	2007-10-17
WO2004016617A1 (en)	2004-02-26
BR0313234A (pt)	2005-06-14
ATE417049T1 (de)	2008-12-15
EP1539765A1 (en)	2005-06-15
KR20060002727A (ko)	2006-01-09
DE60325234D1 (de)	2009-01-22
AU2003248592B2 (en)	2008-04-03
EP1539765B1 (en)	2008-12-10
CN1678615A (zh)	2005-10-05
SE0202430D0 (sv)	2002-08-14
JP2006507241A (ja)	2006-03-02
MXPA05001583A (es)	2005-04-25
AU2003248592A1 (en)	2004-03-03
HK1077571A1 (en)	2006-02-17
IL166416A0 (en)	2006-01-15
US20050239774A1 (en)	2005-10-27
CA2493920A1 (en)	2004-02-26
ZA200501226B (en)	2006-07-26
NZ537882A (en)	2008-02-29
ES2316848T3 (es)	2009-04-16

Legal Events

Date	Code	Title	Description
2010-03-22	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20051259L (no)	2005-05-12	Biaryl-diazabicykloalkanamider som nikotinacetylcholinagonister
ATE433981T1 (de)	2009-07-15	Heterocyclische verbindungen
NO20073551L (no)	2007-08-01	Nikotinacetylkolinreseptorligander
NO20084915L (no)	2009-02-13	Nikotinacetylcholinreseptorligander 101
SE0202463D0 (sv)	2002-08-14	Novel compounds
DE60334536D1 (de)	2010-11-25	Furylverbindungen
HRP20080297T3 (en)	2008-07-31	Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
ATE477256T1 (de)	2010-08-15	Thienylverbindungen
SE0401970D0 (sv)	2004-08-02	Novel compounds
DE602004009200D1 (de)	2007-11-08	Tetrahydrochinazolinderivate als cfr-antagonisten
SE0104250D0 (sv)	2001-12-14	Heterocyclic compounds
SE0302573D0 (sv)	2003-09-26	Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
PL374019A1 (en)	2005-09-19	Benzoxazine derivatives as 5-ht6 modulators and uses thereof
GEP20104964B (en)	2010-04-26	3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
NO20063354L (no)	2006-09-21	Nikotinacetylcholinreseptorligander
SE0300105D0 (sv)	2003-01-16	Diarylmethylidene piperdine derivatives, preparations thereof and uses thereof
SE0203300D0 (sv)	2002-11-07	Novel Compounds
ATE406363T1 (de)	2008-09-15	Methylindole und methylpyrrolopyridine als alpha- 1-adrenerge agonisten
SE0400027D0 (sv)	2004-01-09	Diarylmethyl piperazine derivatives, preparations thereof and uses thereof
MXPA05012116A (es)	2006-02-08	Derivados de diarilmetilideno piperidina y su uso como agonistas del receptor opioide delta.
MX2009001572A (es)	2009-02-19	Derivados de arilpiperazina y usos de los mismos.
MX2007007024A (es)	2007-07-04	Ligandos del receptor acetilcolina nicotinica.
SE0300103D0 (sv)	2003-01-16	Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
ATE465151T1 (de)	2010-05-15	4-aryloxy-chinolin-derivate als 5-ht6-modulatoren
SE0300104D0 (sv)	2003-01-16	Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof